Patent · US Active

Human papilloma virus inhibitors and pharmaceutical compositions containing same

US8440833B2 · kind B2 · utility

0Cited by

3References

17Claims

0Family size

Assignee

Anaconda Pharma · FR

Inventors

Marta Blumenfeld · Paris, FR
Delphine Compere · Sceaux, FR
Jean-Michel Gauthier · Conflans-Sainte-Honorine, FR

Key dates

Filing date	Nov 20, 2008
Grant date	May 14, 2013
Priority date	—
Expiry date	Jul 10, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D295/205
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

HPV inhibitors of formula (I) in which G1 is —NHCO(CH2)n-, where n is an integer between 1 and 4, R3 is —CW(CH2)m—NR4R5 or —CW(CH2)mCH3 or —CN, where W is O, S or NH and m is an integer between 0 and 5, or R3 is one of the following groups: and A is an optionally substituted aryl group and B is an aryl group, preferably a phenyl which is substituted.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.